Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-14-014405
Filing Date
2014-10-16
Accepted
2014-10-17 11:41:58
Documents
1
Effectiveness Date
2014-10-16

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-14-014405.paper CERTNAS 294
  Scanned paper document scanned.pdf   39730
  Complete submission text file 9999999997-14-014405.txt   1286
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-36687 | Film No.: 14007791
SIC: 2834 Pharmaceutical Preparations